Advertisement
Special Article| Volume 46, ISSUE 8, P762-774, December 2022

Remission of Type 2 Diabetes: User’s Guide

Diabetes Canada Clinical Practice Guidelines Expert Working Group:
Published:November 11, 2022DOI:https://doi.org/10.1016/j.jcjd.2022.10.005
      While the “Remission of Type 2 Diabetes” chapter within the Diabetes Canada Clinical Practice Guidelines provides a synthesis of the evidence regarding diabetes remission, this accompanying user’s guide is intended to provide practical support to the health-care provider (HCP) to apply this evidence in clinical practice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ribaric G.
        • Buchwald J.N.
        • McGlennon T.W.
        Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis.
        Obes Surg. 2014; 24: 437-455
        • Committee ADAPP
        8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022.
        Diabetes care. 2021; 45: S113-S124
        • Gregg E.W.
        • Chen H.
        • Wagenknecht L.E.
        • Clark J.M.
        • Delahanty L.M.
        • Bantle J.
        • et al.
        Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes.
        Jama. 2012; 308: 2489-2496
        • Ried-Larsen M.
        • Johansen M.Y.
        • MacDonald C.S.
        • Hansen K.B.
        • Christensen R.
        • Wedell-Neergaard A.S.
        • et al.
        Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial.
        Diabetes Obes Metab. 2019; 21: 2257-2266
        • Lean M.E.J.
        • Leslie W.S.
        • Barnes A.C.
        • Brosnahan N.
        • Thom G.
        • McCombie L.
        • et al.
        Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
        Lancet Diabetes Endocrinol. 2019; 7: 344-355
        • Lean M.E.
        • Leslie W.S.
        • Barnes A.C.
        • Brosnahan N.
        • Thom G.
        • McCombie L.
        • et al.
        Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
        Lancet. 2018; 391: 541-512017
        • Taheri S.
        • Zaghloul H.
        • Chagoury O.
        • Elhadad S.
        • Ahmed S.H.
        • El Khatib N.
        • et al.
        Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
        Lancet Diabetes Endocrinol. 2020; 8: 477-489
        • Aminian A.
        • Vidal J.
        • Salminen P.
        • Still C.D.
        • Nor Hanipah Z.
        • Sharma G.
        • et al.
        Late Relapse of Diabetes After Bariatric Surgery: Not Rare, but Not a Failure.
        Diabetes care. 2020; 43: 534-540
        • Kasama K.
        • Mui W.
        • Lee W.J.
        • Lakdawala M.
        • Naitoh T.
        • Seki Y.
        • et al.
        IFSO-APC consensus statements 2011.
        Obes Surg. 2012; 22: 677-684
        • Salminen P.
        • Gronroos S.
        • Helmio M.
        • Hurme S.
        • Juuti A.
        • Juusela R.
        • et al.
        Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
        JAMA Surg. 2022;
        • Prebtani A.P.H.
        • Bajaj H.S.
        • Goldenberg R.
        • et al.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Reducing the Risk of Developing Diabetes.
        Can J Diabetes. 2018; 42: 20-26
        • Ekoe J.M.
        • Goldenberg R.
        • Katz P.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Screening for Diabetes in Adults.
        Can J Diabetes. 2018; 42: 16-19
        • Punthakee Z.
        • Goldenberg R.
        • Katz P.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.
        Can J Diabetes. 2018; 42: 10-15
      1. Diabetes Canada Updated 2020 Clinical Practice Guidelines Quick Reference Guide: ABCDES Diabetes Care.
        • MacKay D.
        • Chan C.
        • Dasgupta K.
        • et al.
        Remission of Type 2 Diabetes.
        Can J Diabetes. 2022; 48: 753-761
        • Canadian Food Inspection Agency
        Food Labels. Labelling Requirements for Food for Special Dietary Use.
        (Accessed October 3.)
        • Tuomilehto J.
        • Lindström J.
        • Eriksson J.G.
        • et al.
        Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
        N Engl J Med. 2001; 344: 1343-1350
        • KnowlerWC
        • Barrett-Connor E.
        • Fowler S.E.
        • et al.
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Wing R.R.
        • The Look Ahead Research Group
        Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: Four year results of the Look AHEAD trial.
        Arch Intern Med. 2010; 170: 1566-1575
        • Banasiak K.
        • Cleary D.
        • Bajurny V.
        • et al.
        Language Matters – A Diabetes Canada Consensus Statement.
        Can J Diabetes. 2020; 44: 370-373
        • Lipscombe L.
        • Butalia S.
        • Dasgupta K.
        • et al.
        Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
        Can J Diabetes. 2020; 44: 575-591
      2. Ried-Larsen M, Christensen R, Hansen KB, et al. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial. BMJ Open. 2015;5(12):e009764. Published 2015 Dec 9. https://doi.org/10.1136/bmjopen-2015-009764.

        • Diabetes Canada
        Diabetes Canada Position Statement on Low-Carbohydrate Diets for Adults With Diabetes: A Rapid Review.
        Can J Diabetes. 2020; 44: 295-299
        • Tobe S.
        • Gilbert R.E.
        • Jones C.
        • et al.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.Treatment of Hypertension.
        Can J Diabetes. 2018; 42: 186-189
        • Mancini G.B.J.
        • Hegele R.A.
        • Leiter L.A.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Dyslipidemia.
        Can J Diabetes. 2018; 42: 178-185
      3. Diabetes Canada Updated 2020 Clinical Practice Guidelines Quick Reference Guide: Which cardiovascular non-antihyperglycemic medications are indicated for my patient?.
        • Cavero-Redondo I.
        • Peleteiro B.
        • Álvarez-Bueno C.
        • Rodriguez-Artalejo F.
        • Martínez-Vizcaíno V.
        Glycated haemoglobin A1C as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: A systematic review and meta-analysis.
        BMJ Open. 2017; 7e015949
        • Li F.-R.
        • Zhang X.-R.
        • Zhong W.-F.
        • Li Z.-H.
        • Gao X.
        • Kraus V.B.
        • et al.
        Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes.
        The Journal of Clinical Endocrinology & Metabolism. 2019; 104: 3345-3354
        • Sigal R.J.
        • Armstrong M.J.
        • Bacon S.L.
        • et al.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Physical Activity and Diabetes.
        Can J Diabetes. 2018; 42: 54-63
        • Stone J.A.
        • Houlden R.L.
        • Lin P.
        • et al.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Cardiovascular Protection in People With Diabetes.
        Can J Diabetes. 2018; 42: 162-169
        • Lipscombe L.
        • Booth G.
        • Butalia S.
        • et al.
        Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults.
        Can J Diabetes. 2018; 42: 88-103
        • Diabetes Canada
        Prescription for Cardiovascular Protection with Diabetes:.
        • Daly C.A.
        • Fox K.M.
        • Remme W.J.
        • et al.
        The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: Results from the PERSUADE substudy.
        Eur Heart J. 2005; 26: 1369-1378
        • Tjam E.Y.
        • Sherifali D.
        • Steinacher N.
        • Hett S.
        Physiological Outcomes of an Internet Disease Management Program vs. In-person Counselling: A Randomized, Controlled Trial.
        Can J Diabetes. 2006; 30: 397-405